| Bioactivity | Xanthine oxidase-IN-7 (compound1h) is a potent andorally active XO (xanthine oxidase) inhibitor with an IC50 of 0.36 µM. Xanthine oxidase-IN-7 effectively reduces serum uric acid levels. Xanthine oxidase-IN-7 has the potential for the research of hyperuricemia and gout[1]. |
| Target | IC50: 0.36 µM (XO) |
| Name | Xanthine oxidase-IN-7 |
| CAS | 2411698-59-2 |
| Formula | C16H14N4O2 |
| Molar Mass | 294.31 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Gao J, et al. Design, synthesis and biological evaluation of 1-alkyl-5/6-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-1H-indole-3-carbonitriles as novel xanthine oxidase inhibitors. Eur J Med Chem. 2020 Mar 15;190:112077. |
Xanthine oxidase-IN-7
CAS: 2411698-59-2 F: C16H14N4O2 W: 294.31
Xanthine oxidase-IN-7 (compound1h) is a potent andorally active XO (xanthine oxidase) inhibitor with an IC50 of 0.36 µM
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.